National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
November 2, 2010 • Volume 7 / Number 21

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document


In Memoriam: Joan Mauer, Chief of NCI’s Clinical Trials Monitoring Branch

Joan Mauer Joan Mauer

Joan Mauer, chief of the Clinical Trials Monitoring Branch (CTMB) of NCI’s Cancer Therapy Evaluation Program (CTEP), died at her home in Virginia on October 10. She is credited with implementing many processes that have improved and protected the safety and integrity of clinical research studies during her 27 years at NCI.

Mauer joined NCI’s Division of Cancer Treatment and Diagnosis in 1982 and led the Quality and Assurance Section during the 1990s. As chief of CTMB, she headed the program that provides guidance and oversight of the quality assurance and monitoring programs of NCI Cooperative Groups, cancer centers, and phase I clinical trials.

Associate Director of CTEP Dr. Jeff Abrams remarked, “Joan was an especially talented public servant, capable of ensuring high standards for clinical research, yet always able to do this with an endearing, personal touch. We will miss her tremendously.”

NCI to Co-host Scientific Journalism Workshop in Rio de Janeiro

NCI and five national cancer research organizations in Latin America will convene the inaugural “Cancer Research in the Media: Inter-American Workshop for Scientific Journalism” on November 11 and 12 in Rio de Janeiro, Brazil. Journalists from Argentina, Brazil, Chile, Mexico, Uruguay, and the United States will participate in the workshop to discuss health and science, and in particular cancer. The aim is to increase participants’ awareness and understanding of cancer-related topics. The workshop will feature scientific speakers representing a broad spectrum of cancer expertise.

Session themes will include:

  • Cancer research in the laboratory
  • Cancer research in the clinic
  • New technologies used in cancer research
  • Challenges and opportunities in communicating science to the public
  • Evaluating cancer research studies
  • Analyzing and grading coverage of cancer research news

< Previous Section